GSK settles Paxil suit
Pharma Compliance Alert, October 8, 2008
GlaxoSmithKline (GSK) will pay $40 million to settle a class action lawsuit with 42,000 health plans that covered children and adolescents on Paxil, according to a Minneapolis Star Tribune article.
Physicians treated children and adolescents with Paxil, even though that use is not FDA-approved. The health plans argued GSK withheld information about the safety and effectiveness of Paxil use in children and teens.
GSK already settled another class action lawsuit in 2007. The company agreed to pay consumers $63.9 million. GSK did not admit any wrongdoing in either case.
Comments
0 comments on “GSK settles Paxil suit ”
Related Products
Most Popular
- Articles
-
- Q/A: Billing telemetry daily monitoring
- Credentialing monthly: What is the role of the credentials committee in addressing unprofessional conduct?
- 2010 ICD-9 code updates now available online
- Master modifiers to ensure accurate reimbursement
- Radiologist indicted for fraudulently signing reports
- National Quality Forum creates standardized set of data for electronic health records
- H1N1 hits Maine facility
- New report reveals $47 billion in Medicare fraud
- Understand the H1N1 Flu and how to code it
- Don’t be scared into silence: Affiliation letter safeguards allow you to disclose more
- E-mailed
-
- Q/A: Billing telemetry daily monitoring
- Credentialing monthly: What is the role of the credentials committee in addressing unprofessional conduct?
- Radiologist indicted for fraudulently signing reports
- Revised MS.1.20 'huge improvement', out for comment again
- Briefings on Outpatient Rehab Reimbursement and Regulations, December 2009
- New report reveals $47 billion in Medicare fraud
- Press Ganey report: Patient satisfaction increasing across the country
- Residency Program Alert, December 2009
- CMW News: Palliative care programs save hospitals money
- How Unions are Using the Sherman Antitrust Act and Wage Surveys to Organize the Healthcare Industry
- Searched
